Deep Medicine Acquisition Corp.
DMAQNASDAQFinancial Services
$2.96
$-5.43(-64.72%)
Market Cap$12899562
P/E Ratio—
52W High$19.91
52W Low$2.96
Deep Medicine Acquisition Corp. (DMAQ) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DMAQ · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2026-03 | 2025-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $18.88M | $21.86M | $0.00M | $0.00M |
| Cost of Revenue | $9.36M | $7.27M | $0.06M | $0.06M |
| Gross Profit | $9.52M | $14.59M | ($0.06M) | ($0.06M) |
| Gross Margin %(computed) | 50.42% | 66.73% | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $1.91M | $0.41M |
| Total Operating Expenses | $11.01M | $9.42M | $2.11M | $0.41M |
| Operating Income | ($6.10M) | ($2.10M) | ($0.34M) | ($0.46M) |
| Operating Margin %(computed) | -32.32% | -9.62% | — | — |
| Interest Income | $0.27M | $0.11M | $0.00M | $0.00M |
| Interest Expense | ($3.26M) | ($6.93M) | $0.00M | $0.01M |
| Income Before Tax | ($15.23M) | ($8.80M) | ($0.34M) | ($0.41M) |
| Income Tax Expense | $0.00M | $0.00M | $0.06M | ($0.06M) |
| Net Income | ($15.23M) | ($8.80M) | ($0.40M) | ($0.36M) |
| Net Margin %(computed) | -80.66% | -40.24% | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-51.39 | $-756.01 | $-0.17 | $-0.04 |
| Wtd Avg Shares | 0.30M | 11.63M | 2.31M | 8.74M |
| EBITDA | ($6.10M) | ($2.10M) | ($3.99M) | ($0.35M) |
| EBITDA Margin %(computed) | -32.32% | -9.62% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Deep Medicine Acquisition Corp. data
About Deep Medicine Acquisition Corp. (DMAQ) Income Statement
Deep Medicine Acquisition Corp. (DMAQ) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2026, DMAQ reported revenue of $0.02B, gross profit of $0.01B (gross margin 50.42%), and net income of ($0.02B) — a net profit margin of -80.66%.
Frequently asked questions
DMAQ · 4 questionsDeep Medicine Acquisition Corp. (DMAQ) reported revenue of $0.02B for 2026, down 13.6% year-over-year.
DMAQ revenueDMAQ salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09